Biogen reviews

Biogen seems to be lost right now between its small biotech roots and its bigger pharma future, and management directives tug everyone in these two opposite directions daily. Internal process and decision discipline is very weak, and so most work is achieved through endless ad hoc meetings and consensus building. Work-life balance is touted as a value, but the reality is very different, especially at the middle of the organization. Those at the top are perceived as being selected based on relationship and favoritism rather than merit, and sharp-elbowed, mean-spirited bullies are too often touted as "leaders." Current market and industry pressures are exposing a lot of internal mess that wasn't as visible -- or as painful -- in easier times.

It has become 'big business' where there is more focus on the bottom line than on employee satisfaction. Patient focus comes across as lip service from Sr leaders far more than before there was an MS franchise to sell.